Full access
Articles
Published Online: 17 October 2016

An RCT of Effects of Telephone Care Management on Treatment Adherence and Clinical Outcomes Among Veterans With PTSD

Craig S. Rosen, Ph.D., Kathryn J. Azevedo, Ph.D., Quyen Q. Tiet, Ph.D., Carolyn J. Greene, Ph.D., Amanda E. Wood, Ph.D., Patrick Calhoun, Ph.D., Thomas Bowe, Ph.D., Bruce P. Capehart, M.D., Eric F. Crawford, Ph.D., Mark A. Greenbaum, M.S., M.A., Alex H. S. Harris, Ph.D., Michael Hertzberg, M.D., Steven E. Lindley, M.D., Ph.D., Brandy N. Smith, B.A., and Paula P. Schnurr, Ph.D.Authors Info & Affiliations
Publication: Psychiatric Services
Volume 68, Number 2
https://doi.org/10.1176/appi.ps.201600069
PDF/EPUB

Abstract

Objective:

This study assessed whether adding telephone care management to usual outpatient mental health care improved treatment attendance, medication compliance, and clinical outcomes of veterans with posttraumatic stress disorder (PTSD).

Methods:

In a multisite randomized controlled trial, 358 veterans were assigned to either usual outpatient mental health treatment (N=165) or usual care plus twice-a-month telephone care management (TCM) and support in the first three months of treatment (N=193). Treatment utilization and medication refills were determined from U.S. Department of Veterans Affairs administrative data. PTSD, depression, quality of life, aggressive behavior, and substance use were assessed with self-report questionnaires at intake, four months, and 12 months.

Results:

Telephone care managers reached 95% of TCM participants (N=182), completing an average 5.1 of 6.0 planned telephone calls. During the three-month intervention period, TCM participants completed 43% more mental health visits (M±SD=5.9±6.8) than did those in usual care (4.1±4.2) (incident rate ratio=1.36, χ2=6.56, df=1, p<.01). Treatment visits in the nine-month follow-up period and medication refills did not differ by condition. Only 9% of participants were scheduled to receive evidence-based psychotherapy. Slopes of improvement in PTSD, depression, alcohol misuse, drug problems, aggressive behavior, and quality of life did not differ by condition or treatment attendance.

Conclusions:

TCM improved PTSD patients’ treatment attendance but not their outcomes. TCM can enhance treatment engagement, but outcomes depend on the effectiveness of the treatments that patients receive.
Premature treatment dropout and poor medication compliance are common challenges in treating people with mental disorders (1–4). Less than two-thirds of veterans with prescriptions for psychiatric medications for treatment of posttraumatic stress disorder (PTSD) refill their medications for three or four months, as recommended in practice guidelines (4–6). Only 64% of Iraq and Afghanistan veterans who initiate psychotherapy complete a full course of treatment (7). Other studies have shown that only 25% to 35% of U.S. Department of Veterans Affairs (VA) patients receiving psychotherapy for PTSD complete eight or more sessions (4,8).
Several factors may limit engagement in PTSD treatments (9). Veterans may doubt whether psychotherapy and medications are effective (10–13). People may delay psychotherapy to avoid talking about traumatic events (14,15). PTSD-related alienation and distrust might interfere with developing a strong therapeutic alliance (16,17). Scheduling difficulties and travel distances can be barriers to care (12,18,19). Some studies have shown that compared with Vietnam veterans, veterans of Iraq and Afghanistan conflicts complete fewer PTSD treatment visits, perhaps because of less mental health treatment experience (8,9), lower readiness for change, different comorbid conditions, greater confidentiality concerns, or competing time demands (18,20–23).
Care management programs that include telephone support can improve treatment engagement and outcomes for depression or alcohol problems managed in primary care (24,25). Brief motivational interventions via telephone can improve acceptance of mental health referrals (26,27). Telephone support can also reduce relapse after addiction treatment (28).
There has been less research on using telephone support to aid PTSD treatment retention. Two trials of care management that included a telephone care component with veterans recruited from primary care showed mixed results. One study found that care management improved attendance but not outcomes (29). Another study found that a combination of evidence-based psychotherapy via video teleconferencing and care management significantly improved both treatment attendance and outcomes (30). A trial with veterans being discharged from residential PTSD treatment found that telephone support had no effect on either aftercare attendance or outcomes, given that nearly all of these patients were already participating in aftercare (31). No prior trials have tested a care management intervention to improve attendance and outcomes of PTSD patients in mental health clinics, although premature treatment dropout is common in these settings (8,21).

Study Hypotheses

The goal of this study was to test whether telephone care management (TCM) increases treatment adherence of veterans initiating a new phase of outpatient mental health specialty treatment for PTSD (Figure 1). Our primary hypothesis was that compared with patients receiving only usual care, those randomly assigned to usual care plus three months of TCM would attend more mental health appointments during the three-month intervention period and during the nine-month follow-up period and would have higher medication possession ratios (MPRs) over the 12-month study period, indicating more prescription refills for prazosin and for selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). Our second hypothesis was that patients assigned to the TCM condition would show greater reductions in PTSD and depression symptoms over 12 months than would those receiving usual care. Moreover, the effects of TCM on PTSD and depression would be mediated by patients attending more mental health appointments and having higher MPRs. Our tertiary hypotheses were that patients in the TCM condition would have greater improvements in aggressive behavior, alcohol misuse, drug use, and quality of life than those receiving usual care.
FIGURE 1. Telephone care management logic model for veterans with PTSD
Additional exploratory analyses examined whether risk factors for poor treatment engagement moderated the effects of TCM on treatment attendance and medication refills. We hypothesized that the effects of TCM relative to usual care would be strongest among patients who participated in less mental health treatment in the year before the study (8), lived farther from the nearest VA clinic (12), served in Iraq or Afghanistan (12,23), had poorer therapeutic alliance with their clinician (17), or had lower expectations that mental health treatment would resolve their presenting problems (11,12).

Methods

Participants

A total of 1,346 veterans were assessed for eligibility between March 2009 and April 2013 from outpatient mental health programs at three VA medical centers. These included three PTSD specialty clinics, one Iraq-Afghanistan veteran clinic, and one general mental health clinic. Veterans were eligible to participate if they were newly entering outpatient PTSD treatment or were beginning a new phase of treatment (such as transitioning from a psychoeducation group to other psychotherapy). Participants were recruited before their third session of the new treatment. A total of 190 participants were excluded because they were continuing patients, dropped out of care before completing enrollment, were starting residential or inpatient treatment, were active duty military personnel, or were too cognitively impaired to consent. Participants were recruited through provider referral or via mailed letter, which was approved by the institutional review board that reviewed the study (the letter included an opt-out option), followed by a telephone call. Interested patients met with a research assistant who explained the study and obtained consent. Of 1,156 eligible patients, 358 (31%) agreed to participate and completed a baseline survey.
Treatment plans were available for 350 participants at the time of initial assessment; these plans were diverse, including group psychoeducation, other group therapies, individual psychotherapy, case management, or psychiatric management, but did not differ by condition. Sixty-three percent (N=220) of the participating veterans were scheduled to be seen weekly, 20% (N=71) were scheduled to be seen monthly or biweekly, 11% (N=39) had psychotherapy of no specified frequency, and 6% (N=20) had no psychosocial treatment. Only 31 participants (9%) were scheduled to receive one of the evidence-based therapies for PTSD: cognitive processing therapy (CPT; 32) or prolonged exposure (33). A total of 240 participants (68%) were prescribed an SSRI or SNRI during the study period, of whom 200 (83%) had continuations of prior prescriptions, 25 (10%) had new prescriptions initiated during the three-month intervention period, and 15 (6%) had prescriptions initiated during the nine-month follow-up. Eighty-seven participants (24%) were prescribed prazosin, including 60 (17%) with continuations of prior prescriptions, ten (3%) with new prescriptions initiated during the intervention period, and 17 (5%) with new prescriptions initiated during follow-up. Because of the small number of new prescriptions, new and continued prescriptions were combined in all analyses.

Procedures

Study procedures were overseen by institutional review boards at each study site, and all of the veterans provided written informed consent to participate. Random assignments were made centrally by using the randomization technique of Efron (34) and then stratifying within site, by gender, and by whether participants had served in Iraq or Afghanistan. After random assignment, one participant transferred to a residential treatment program and another withdrew and asked that his data not be used, leaving a final sample of 356, of which 191 were in the TCM intervention and 165 were in usual care. Surveys at four- and 12-month follow-ups were obtained by mail, with mail and telephone follow-up, by using the Dillman method (35). Completion rates were 68% (N=242) and 60% (N=213), respectively. [A figure in the online supplement to this article shows the study conditions and participation rates.]

Telephone Care Intervention

Participants randomly assigned to usual care received regular care from their counselors or psychiatrists. Participants in the TCM arm received usual care augmented by fortnightly telephone monitoring and support during their first three months of treatment. The telephone monitoring intervention was delivered from a centralized call center by clinical psychology graduate students supervised by a clinical psychologist. If participants did not answer the telephone, the care manager left a message and toll-free call-back number and made two additional contact attempts. After three attempts, participants were not contacted until their next scheduled call. If the telephone number was disconnected, we attempted to obtain a new number from a family member or friend whom the participant had provided as a contact.
Telephone care managers followed a semiscripted protocol to assess participants’ treatment attendance, medication compliance and side effects, symptom severity (PTSD, depression, and anger were each assessed on a 1–10 Likert scale, with higher scores indicating worse symptoms), self-efficacy for coping with symptoms, substance use, suicidality, and risk for violence (36). Telephone care managers verbally reinforced positive behaviors, such as using coping skills or adhering to treatment. They provided brief problem-solving support or motivation enhancement to help address behaviors that could interfere with treatment, such as missing appointments, misusing substances, or not communicating concerns to providers. Telephone care managers alerted their supervisor and the participant’s provider if the participant was at risk of self-harm and informed the participant’s provider if symptoms increased or if substance abuse began.

Measures

The primary outcomes were assessed at baseline, four months, and 12 months with the DSM-IV version of the PTSD Checklist (PCL; 37) and the Center for Epidemiological Studies Depression Scale (CES-D; 38). Substance use outcomes were assessed with the alcohol and drug composite scores from the self-report version of the Addiction Severity Index (ASI; 39,40). Aggressive behavior was assessed with a six-item index (range 0 to 8) adapted from the Conflict Tactics Scale (41), which expands on a four-item index widely used with VA patients (42). Quality of life was assessed with a scale developed for the Veterans Affairs Military Stress Treatment Assessment study (43).
Mental health outpatient treatment visits during the three-month intervention period and the nine-month follow-up period were determined from the National Patient Care Database. Mental health visits were classified as either PTSD psychotherapy (encounters with both a PTSD diagnosis and a psychotherapy procedure code) or other mental health visits (mental health visits without a PTSD diagnosis or visits for PTSD which did not include psychotherapy). For participants prescribed psychiatric medications, MPRs (calculated as days’ supply of medications divided by total days) for the 12-month study period were determined from the Decision Support System Pharmacy National Data Extracts according to procedures used by Lockwood and colleagues (44). Distance from participants’ homes to the nearest VA clinic or VA medical center was determined from VA administrative data. At baseline, four months, and 12 months, therapeutic alliance with the mental health provider that participants saw most often was assessed with the short form of the Working Alliance Inventory (45). At those same time points, treatment outcome expectations were assessed with a procedure developed by Battle and colleagues (46).

Statistical Analysis

Analyses were conducted on an intent-to-treat basis, with multiple imputation of missing data (47,48). All analyses were conducted with R version 2.9.2 (49), and multiple imputations were completed with the R MICE library (50). Our sample size provided 90% power to detect small (d=.20) effects of condition on outcomes. To address our primary hypotheses, we used negative binomial regression to assess the effect of study condition on number of PTSD psychotherapy visits and total mental health visits completed, and we used linear regression to determine the effects of study condition on MPRs. To address our secondary and tertiary hypotheses, we used mixed-effects regression models to assess the effect of condition and study site on slope of improvement in each of our clinical outcomes over the 12-month study period and to assess whether treatment attendance and MPR mediated these effects. All models included fixed effects for study site and for treatment utilization in the year before the study. Exploratory regression analyses tested whether there were significant interactions between treatment condition and each of our five moderators in predicting four outcomes: treatment attendance during the three-month intervention period, MPRs over the 12 months of the study, and slopes of PTSD and depression symptoms over the 12 months of the study.

Results

Participant characteristics are shown in Table 1.
TABLE 1. Characteristics among veterans assigned to telephone care management (TCM) or to usual care for PTSD, by treatment conditiona
  TCM (N=188–192)Usual care (N=161–165)  
CharacteristicNN%N%χ2df
Female35531162213.551
OEF-OIF veteranb355100548853.021
Marital status356    6.045
 Married 103548853  
 Remarried 8453  
 Divorced 35183823  
 Separated 95138  
 Widowed 2132  
 Never married 34181811  
Race-ethnicity349    5.207
 White, not Hispanic 95517546  
 African American, not Hispanic 45244830  
 Hispanic, white 2212149  
 Hispanic, African American 4253  
 American Indian 1143  
 Asian 4243  
 Pacific Islander 5332  
 Other 11696  
Co-occurring diagnoses354      
 Depression 108578853.501
 Anxiety (other than PTSD) 593133205.76*1
 Substance use disorder 31163561.341
 Psychotic disorder 1111.011
 Bipolar disorder 126532.121
Service-connected disability 1316910966.431
Scheduled for CPT or PEc 20111171.591
 NMSDMSDtdf
Age35647.71.148.41.1–.46354
Therapeutic allianced35535.34.245.13.6–1.76351
Treatment expectanciese3361.6.21.9.2–1.00354
Outpatient mental health visits in prior year35411.41.28.91.01.55352
Distance from home to clinic (miles)35413.010.213.810.8.73353
a
The only significant difference in participant characteristics by condition was that more (p<.02) patients in the TCM than in the usual care condition had co-occurring anxiety diagnoses.
b
Service in Operation Enduring Freedom or Operation Iraqi Freedom
c
CPT, cognitive processing therapy; PE, prolonged exposure therapy
d
Measured with the short-form Working Alliance Inventory. Possible scores range from 12 to 84, with higher scores indicating stronger alliance with the outpatient provider.
e
Treatment expectancy scores range from –5 to 5, with more positive scores indicating greater expectation that treatment could improve the presenting problems.
*
p<.05
Telephone care managers contacted 182 (95%) of the 191 remaining participants in the intervention condition and completed a mean±SD of 5.1±1.3 of the six planned calls for each participant. Telephone contact duration ranged from one to 92 minutes (25.1±11.1). For 125 (65%) TCM participants, care managers informed their providers of new problems that emerged during the phone calls. These problems included increased symptoms (reported in 324 out of 926 phone calls, 35%), problems with scheduling or attending appointments (222 calls, 24%), suicidal ideation (65 calls, 7%), aggressive ideation (56 calls, 6%), heavy drinking (74 calls, 8%), drug use (54 calls, 6%), or medication noncompliance (55 calls, 6%).

Adverse Events

We had 13 non-study-related adverse events. One participant was hospitalized for alcohol withdrawal and was later reported deceased. One participant voluntarily entered a residential alcohol treatment program and was excluded from the study because he was no longer receiving outpatient care. Two participants had a psychiatric hospitalization for suicidal ideation. Five participants were hospitalized for medical reasons. Two participants were incarcerated, and two were in car accidents.

Treatment Utilization

During the three-month intervention period, participants in the TCM condition completed 43% more mental health visits (5.9±6.8) than did those in usual care (4.1±4.2) (incident rate ratio [IRR]=1.36, χ2=6.56, df=1, p<.01). More specifically, veterans in the TCM condition completed significantly more sessions of psychotherapy for PTSD (3.1±5.2) than did those receiving usual care (2.2±3.3, IRR=1.45, χ2=8.4, df=1, p<.001). Nearly half of the usual care participants (47%, N=77) completed no PTSD psychotherapy visits, compared with 35% (N=67) of those receiving TCM (Figure 2). Yet, few participants in either the TCM (15%, N=29) or the usual care (10%, N=16) conditions completed eight or more sessions of psychotherapy for PTSD during the initial three-month period. The number of other mental health visits (nonpsychotherapy or non-PTSD visits, or a combination) completed during the intervention period did not differ significantly between the TCM (2.5±3.0) and usual care (1.9±2.1) conditions (Table 2). The number of PTSD psychotherapy visits or other mental health visits in the nine-month postintervention period did not differ by condition.
FIGURE 2. Psychotherapy visits for PTSD by veterans receiving telephone care management or usual care over three months
TABLE 2. Treatment utilization of veterans randomly assigned to receive telephone care management or treatment as usuala
 Telephone care managementTreatment as usual   
CharacteristicNMSDNMSDIRRbχ2cp
3-month intervention period         
 PTSD psychotherapy visits1893.325.241652.183.261.458.40<.01
 Other mental health visits1892.542.961651.902.101.263.14.07
9-month follow-up period         
 PTSD psychotherapy visits1895.4111.831654.857.991.10.59.44
 Other mental health visits1895.718.611654.195.321.12.91.34
12-month study period MPRd         
 SSRI or SNRIe124.54.30116.57.27−.03.58.45
 Prazosin36.45.2951.45.27−.02.16.69
a
Values shown are estimated marginal means, with controls for site and for value of the outcome variable in the 12 months prior to the study.
b
Incident rate ratio, an exponentiated beta weight for effect of treatment condition in a negative binomial model that controlled for number of PTSD psychotherapy visits and number of other mental health visits in the year before the study
c
df=1
d
MPR, medication possession ratio
e
SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin-norepinephrine reuptake inhibitor
There was no difference by condition in MPRs for SSRIs, SNRIs, or prazosin prescriptions. None of the risk factors for low attendance (prior-year treatment visits, distance to care, treatment expectancies, therapeutic alliance, or being a veteran of Iraq or Afghanistan conflicts) moderated the effects of TCM on either the number of PTSD psychotherapy sessions or other mental health visits completed during the intervention period.

Clinical Outcomes

There was no improvement in clinical outcomes. The 12-month slopes of PTSD, depression, alcohol problems, drug problems, aggressive behavior, and quality of life did not improve significantly over time and did not differ by intervention condition (Table 3).
TABLE 3. Clinical outcomes by condition and time for veterans randomly assigned to receive telephone care management (TCM) or treatment as usuala
 Baseline4 month12 monthSlope
 TCMUsual careTCMUsual careTCMUsual care Time ×
MeasureMSDMSDMSDMSDMSDMSDTimebconditionc
PCLd63.8313.3763.9412.9160.8914.1862.3313.6659.2715.5961.9814.85–1.43–2.68
CES-De36.6110.5036.1110.8135.7211.7636.6711.3434.8711.3035.3011.07–1.00−.77
QOLf3.301.013.551.103.341.113.431.103.481.063.431.12–.12.30
ASI alcoholg.13.18.12.15.12.18.13.17.13.19.15.20.03–.03
ASI drugg.03.05.02.04.03.07.03.05.03.07.03.08.02–.01
Aggressionh5.251.885.181.915.681.775.471.835.691.985.562.02.38.05
a
Missing data have been imputed.
b
Regression estimate of slope of change over 12-month study period in the usual care condition. All were not statistically significant.
c
Regression estimates of incremental change over 12 months in TCM compared with the usual care group. All slope effects were not statistically significant.
d
PTSD Checklist. Possible scores range from 17 to 85, with higher scores indicating more severe symptoms.
e
Center for Epidemiological Studies Depression Scale. Possible scores range from 0 to 60, with higher scores indicating more severe symptoms.
f
The ten-item quality of life subscale of the Veterans Affairs Military Stress Treatment Assessment. Possible scores range from 1 to 7, with higher scores indicating greater satisfaction.
g
Addiction Severity Index. Alcohol and drug composite scores range from 0 to 1, with higher scores indicating more severe symptoms.
h
The six-item index of aggressive behavior, derived from the Conflict Tactics Scale. Possible scores range from 0 to 6, with higher scores indicating more severe symptoms.
Our model of TCM presumed that increasing treatment visits and medication refills would improve participant outcomes. To explore this hypothesized mediation mechanism, we examined the associations between each of our dose-of-care measures (PTSD psychotherapy visits, total mental health visits, SSRI or SNRI MPR, and prazosin MPR) and slope of improvement on each clinical outcome (PTSD, depression, alcohol problems, drug problems, aggressive behavior, and quality of life). None of the dose-of-care indicators was significantly associated with any clinical outcome.

Discussion

We hypothesized that TCM would increase treatment attendance and that this would improve participants’ PTSD, depression, and other clinical outcomes. Consistent with prior studies, TCM improved treatment attendance (26,27,29). This effect did not persist in the follow-up period after telephone contacts stopped. TCM had no effect on medication refills, perhaps because most patients were continuing existing prescriptions. Telephone monitoring may be more valuable for patients initiating a new prescription, both to manage side effects and to ensure sufficient adherence to evaluate whether the new medication is helpful.
Our hypotheses that TCM would directly or indirectly improve clinical outcomes were not supported. A mean difference of 1.5 in-person visits over three months may not have been large enough to be clinically meaningful. Our finding that only 10% to 15% of participants completed eight or more sessions of PTSD psychotherapy during the three-month intervention period is similar to some prior reports (4).
The impact of TCM may have been limited by the heterogeneity of treatments that participants received. We accepted patients starting any type of treatment for PTSD, including trauma-focused therapy, other weekly psychotherapies, psychoeducation groups, art therapy, case management, or medication management. Not all of these are likely to be equally effective (51,52). Consistent with some other VA studies (53,54), only a small proportion of all PTSD psychotherapy patients were scheduled for evidence-based psychotherapies.
This treatment diversity may explain why pre-post changes in participant outcomes were small and unrelated to the number of mental health treatment sessions participants attended. Another study of veterans receiving usual VA care found modest improvements overall and no relation between treatment dose and outcomes (55). Other research found that adherence to SSRI and SNRI medications did not lower risk of rehospitalization after discharge from residential PTSD treatment (44). Yet when veterans initiated prolonged exposure therapy, a psychotherapy known to be efficacious for PTSD, those who completed a full course of treatment had better outcomes than those who dropped out (56). This suggests that adherence improves outcomes when the treatment itself is highly effective.
The clinical impact of care management likely depends on the effectiveness of the treatment it is supporting. In the RESPECT-PTSD trial, conducted in primary care, collaborative care improved treatment attendance but not clinical outcomes (29). In that study the dose of psychotherapy was small, and few participants received trauma-focused psychotherapy. In contrast, the collaborative care arm in the Telemedicine Outreach for PTSD (TOP) trial provided remote evidence-based CPT to participants who wanted it, in addition to telephone support and pharmacology consultation (30). The TOP collaborative care arm had significantly better clinical outcomes than usual care, and the effect was mediated by the proportion of participants (25% versus 5%) who completed CPT.
This study had several limitations. We had too few participants receiving prolonged exposure therapy or CPT to test whether the clinical effects of TCM were moderated by type of treatment. This study was conducted with patients who had already initiated mental health treatment. Effects of telephone contact may be stronger for people not yet engaged in care (57,58). This study was conducted within a single integrated health care system, the Veterans Health Administration. It is unclear how well these results generalize to other care settings, where services may be more fragmented. Furthermore, it was conducted with predominantly male veterans, so findings may not generalize to nonveterans or to women.

Conclusions

TCM increased veterans’ attendance in PTSD treatment but did not improve their clinical outcomes. A growing literature confirms that TCM can improve patients’ entry into and retention in mental health treatment. However, the clinical impact of telephone support is contingent on the overall effectiveness of the mental health treatment that is being supported.

Supplementary Material

File (appi.ps.201600069.ds001.pdf)

References

1.
Chong WW, Aslani P, Chen TF: Effectiveness of interventions to improve antidepressant medication adherence: a systematic review. International Journal of Clinical Practice 65:954–975, 2011
Crossref
PubMed
Google Scholar
2.
Olfson M, Mojtabai R, Sampson NA, et al: Dropout from outpatient mental health care in the United States. Psychiatric Services 60:898–907, 2009
Crossref
PubMed
Google Scholar
3.
Schottenbauer MA, Glass CR, Arnkoff DB, et al: Nonresponse and dropout rates in outcome studies on PTSD: review and methodological considerations. Psychiatry 71:134–168, 2008
Crossref
PubMed
Google Scholar
4.
Spoont MR, Murdoch M, Hodges J, et al: Treatment receipt by veterans after a PTSD diagnosis in PTSD, mental health, or general medical clinics. Psychiatric Services 61:58–63, 2010
Crossref
PubMed
Google Scholar
5.
Jain S, Greenbaum MA, Rosen CS: Do veterans with PTSD receive first line pharmacotherapy for PTSD? Results from the Longitudinal Veterans Health Survey. Primary Care Companion for CNS Disorders 14:2, 2012
Google Scholar
6.
Veterans Administration/Department of Defense Clinical Practice Guideline Working Group: Management of Post-Traumatic Stress. Washington, DC, Office of Quality and Performance, 2010
Google Scholar
7.
Goetter EM, Bui E, Ojserkis RA, et al: A systematic review of dropout from psychotherapy for posttraumatic stress disorder among Iraq and Afghanistan combat veterans. Journal of Traumatic Stress 28:401–409, 2015
Crossref
PubMed
Google Scholar
8.
Aakre JM, Himelhoch S, Slade EP: Mental health service utilization by Iraq and Afghanistan veterans after entry into PTSD specialty treatment. Psychiatric Services 65:1066–1069, 2014
Crossref
PubMed
Google Scholar
9.
Andersen RM: Revisiting the behavioral model and access to medical care: does it matter? Journal of Health and Social Behavior 36:1–10, 1995
Crossref
PubMed
Google Scholar
10.
Kehle SM, Polusny MA, Murdoch M, et al: Early mental health treatment-seeking among US National Guard soldiers deployed to Iraq. Journal of Traumatic Stress 23:33–40, 2010
PubMed
Google Scholar
11.
Dew SE, Bickman L: Client expectancies about therapy. Mental Health Services Research 7:21–33, 2005
Crossref
PubMed
Google Scholar
12.
Spoont MR, Nelson DB, Murdoch M, et al: Impact of treatment beliefs and social network encouragement on initiation of care by VA service users with PTSD. Psychiatric Services 65:654–662, 2014
Crossref
PubMed
Google Scholar
13.
DeViva JC, Sheerin CM, Southwick SM, et al: Correlates of VA mental health treatment utilization among OEF/OIF/OND veterans: resilience, stigma, social support, personality, and beliefs about treatment. Psychological Trauma: Theory, Research, Practice, and Policy 8:310–318, 2016.
Crossref
PubMed
Google Scholar
14.
Zayfert C, Deviva JC, Becker CB, et al: Exposure utilization and completion of cognitive behavioral therapy for PTSD in a “real world” clinical practice. Journal of Traumatic Stress 18:637–645, 2005
Crossref
PubMed
Google Scholar
15.
Hundt NE, Mott JM, Miles SR, et al: Veterans’ perspectives on initiating evidence-based psychotherapy for posttraumatic stress disorder. Psychological Trauma: Theory, Research, Practice, and Policy 7:539–546, 2015
Crossref
PubMed
Google Scholar
16.
Horvath AO, Del Re AC, Flückiger C, et al: Alliance in individual psychotherapy. Psychotherapy 48:9–16, 2011
Crossref
PubMed
Google Scholar
17.
Keller SM, Zoellner LA, Feeny NC: Understanding factors associated with early therapeutic alliance in PTSD treatment: adherence, childhood sexual abuse history, and social support. Journal of Consulting and Clinical Psychology 78:974–979, 2010
Crossref
PubMed
Google Scholar
18.
Stecker T, Shiner B, Watts BV, et al: Treatment-seeking barriers for veterans of the Iraq and Afghanistan conflicts who screen positive for PTSD. Psychiatric Services 64:280–283, 2013
Crossref
PubMed
Google Scholar
19.
Pfeiffer PN, Glass J, Austin K, et al: Impact of distance and facility of initial diagnosis on depression treatment. Health Services Research 46:768–786, 2011
Crossref
PubMed
Google Scholar
20.
Crawford EF, Elbogen EB, Wagner HR, et al: Surveying treatment preferences in US Iraq-Afghanistan veterans with PTSD symptoms: a step toward veteran-centered care. Journal of Traumatic Stress 28:118–126, 2015.
Crossref
PubMed
Google Scholar
21.
Jakupcak M, Hoerster KD, Blais RK, et al: Readiness for change predicts VA mental healthcare utilization among Iraq and Afghanistan war veterans. Journal of Traumatic Stress 26:165–168, 2013.
Crossref
PubMed
Google Scholar
22.
Harpaz-Rotem I, Rosenheck RA: Serving those who served: retention of newly returning veterans from Iraq and Afghanistan in mental health treatment. Psychiatric Services 62:22–27, 2011
Crossref
PubMed
Google Scholar
23.
Kehle-Forbes SM, Meis LA, Spoont MR, et al: Treatment initiation and dropout from prolonged exposure and cognitive processing therapy in a VA outpatient clinic. Psychological Trauma: Theory, Research, Practice, and Policy 8:107–114, 2016.
Crossref
PubMed
Google Scholar
24.
Oslin DW, Sayers S, Ross J, et al: Disease management for depression and at-risk drinking via telephone in an older population of veterans. Psychosomatic Medicine 65:931–937, 2003
Crossref
PubMed
Google Scholar
25.
Williams JW Jr, Gerrity M, Holsinger T, et al: Systematic review of multifaceted interventions to improve depression care. General Hospital Psychiatry 29:91–116, 2007
Crossref
PubMed
Google Scholar
26.
Seal KH, Abadjian L, McCamish N, et al: A randomized controlled trial of telephone motivational interviewing to enhance mental health treatment engagement in Iraq and Afghanistan veterans. General Hospital Psychiatry 34:450–459, 2012
Crossref
PubMed
Google Scholar
27.
Zanjani F, Miller B, Turiano N, et al: Effectiveness of telephone-based referral care management, a brief intervention to improve psychiatric treatment engagement. Psychiatric Services 59:776–781, 2008
Crossref
PubMed
Google Scholar
28.
McKay JR, Lynch KG, Shepard DS, et al: The effectiveness of telephone-based continuing care in the clinical management of alcohol and cocaine use disorders: 12-month outcomes. Journal of Consulting and Clinical Psychology 72:967–979, 2004
Crossref
PubMed
Google Scholar
29.
Schnurr PP, Friedman MJ, Oxman TE, et al: RESPECT-PTSD: re-engineering systems for the primary care treatment of PTSD, a randomized controlled trial. Journal of General Internal Medicine 28:32–40, 2013
Crossref
PubMed
Google Scholar
30.
Fortney JC, Pyne JM, Kimbrell TA, et al: Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry 72:58–67, 2015
Crossref
PubMed
Google Scholar
31.
Rosen CS, Tiet QQ, Harris AH, et al: Telephone monitoring and support after discharge from residential PTSD treatment: a randomized controlled trial. Psychiatric Services 64:13–20, 2013
Crossref
PubMed
Google Scholar
32.
Resick PA, Schnicke MK: Cognitive processing therapy for sexual assault victims. Journal of Consulting and Clinical Psychology 60:748–756, 1992
Crossref
PubMed
Google Scholar
33.
Foa E, Hembree E, Rothbaum BO: Prolonged Exposure Therapy for PTSD: Emotional Processing of Traumatic Experiences, Therapist Guide. New York, Oxford University Press, 2007
Crossref
Google Scholar
34.
Efron B: Forcing a sequential experiment to be balanced. Biometrika 58:403–417, 1971
Crossref
Google Scholar
35.
Dillman DA: Mail and Telephone Surveys: The Total Design Method. New York, Wiley, 1978
Google Scholar
36.
Rosen CS, DiLandro C, Corwin KN, et al: Telephone monitoring and support for veterans with chronic posttraumatic stress disorder: a pilot study. Community Mental Health Journal 42:501–508, 2006
Crossref
PubMed
Google Scholar
37.
Blanchard EB, Jones-Alexander J, Buckley TC, et al: Psychometric properties of the PTSD Checklist (PCL). Behaviour Research and Therapy 34:669–673, 1996
Crossref
PubMed
Google Scholar
38.
Radloff LS: The CES-D Scale: a self report depression scale for research in the general population. Applied Psychological Measurement 1:385–401, 1977
Crossref
Google Scholar
39.
McLellan AT, Kushner H, Metzger D, et al: The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 9:199–213, 1992
Crossref
Google Scholar
40.
Rosen CS, Henson BR, Finney JW, et al: Consistency of self-administered and interview-based Addiction Severity Index composite scores. Addiction 95:419–425, 2000
Crossref
PubMed
Google Scholar
41.
Straus M: Measuring intrafamily conflict and violence: the Conflict Tactics Scales. Journal of Marriage and the Family 41:75–88, 1979
Crossref
Google Scholar
42.
Hoff R, Shea J, Gray S, et al: The Long Journey Home XXI, Treatment of Posttraumatic Stress Disorder (PTSD): Department of Veterans Affairs: Fiscal Year 2012 Service Delivery and Performance. West Haven, Conn, VA Northeast Program Evaluation Center, 2013
Google Scholar
43.
Fontana A, Ruzek JI, McFall M, et al: The Veterans Affairs Military Stress Treatment Assessment (VAMSTA): A Descriptive and Monitoring Instrument for the Treatment of PTSD and Comorbid Disorders. West Haven, Conn, VA Northeast Program Evaluation Center, 2006
Google Scholar
44.
Lockwood A, Steinke DT, Botts SR: Medication adherence and its effect on relapse among patients discharged from a Veterans Affairs posttraumatic stress disorder treatment program. Annals of Pharmacotherapy 43:1227–1232, 2009
Crossref
PubMed
Google Scholar
45.
Horvath AO, Greenberg LS: Development and validation of the Working Alliance Inventory. Journal of Counseling Psychology 36:223–233, 1989
Crossref
Google Scholar
46.
Battle CC, Imber SD, Hoehn-Saric R, et al: Target complaints as criteria of improvement. American Journal of Psychotherapy 20:184–192, 1966
Crossref
PubMed
Google Scholar
47.
Rubin DB: Inference and missing data. Biometrika 63:581–592, 1976
Crossref
Google Scholar
48.
Schafer JL, Graham JW: Missing data: our view of the state of the art. Psychological Methods 7:147–177, 2002
Crossref
PubMed
Google Scholar
49.
R Development Core Team: R: A Language and Environment for Statistical Computing. Vienna, Austria, R Foundation for Statistical Computing, 2009
Google Scholar
50.
Van Buuren S, Oudshoorn CGM: Multivariate Imputation by Chained Equations. R Package Version 1.14, 2005. Vienna, R Foundation for Statistical Computing. ftp://85.158.30.137/lib.stat.cmu.edu/R/CRAN/src/contrib/.Descriptions/mice.html
Google Scholar
51.
Bradley R, Greene J, Russ E, et al: A multidimensional meta-analysis of psychotherapy for PTSD. American Journal of Psychiatry 162:214–227, 2005
Crossref
PubMed
Google Scholar
52.
Goodson J, Helstrom A, Halpern JM, et al: Treatment of posttraumatic stress disorder in US combat veterans: a meta-analytic review. Psychological Reports 109:573–599, 2011
Crossref
PubMed
Google Scholar
53.
Watts BV, Shiner B, Zubkoff L, et al: Implementation of evidence-based psychotherapies for posttraumatic stress disorder in VA specialty clinics. Psychiatric Services 65:648–653, 2014
Crossref
PubMed
Google Scholar
54.
Mott JM, Mondragon S, Hundt NE, et al: Characteristics of US veterans who begin and complete prolonged exposure and cognitive processing therapy for PTSD. Journal of Traumatic Stress 27:265–273, 2014
Crossref
PubMed
Google Scholar
55.
Shin HJ, Greenbaum MA, Jain S, et al: Associations of psychotherapy dose and SSRI or SNRI refills with mental health outcomes among veterans with PTSD. Psychiatric Services 65:1244–1248, 2014
Crossref
PubMed
Google Scholar
56.
Eftekhari A, Ruzek JI, Crowley JJ, et al: Effectiveness of national implementation of prolonged exposure therapy in Veterans Affairs care. JAMA Psychiatry 70:949–955, 2013
Crossref
PubMed
Google Scholar
57.
McFall M, Malte C, Fontana A, et al: Effects of an outreach intervention on use of mental health services by veterans with posttraumatic stress disorder. Psychiatric Services 51:369–374, 2000
Crossref
PubMed
Google Scholar
58.
Stecker T, McHugo G, Xie H, et al: RCT of a brief phone-based CBT intervention to improve PTSD treatment utilization by returning service members. Psychiatric Services 65:1232–1237, 2014
Crossref
PubMed
Google Scholar

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services

Cover: Love of Winter, by George Wesley Bellows, 1914. Oil on canvas. Friends of American Art Collection (1914.1018), the Art Institute of Chicago. Photography ©The Art Institute of Chicago, www.artic.edu.

Psychiatric Services
Volume 68 • Number 2 • February 01, 2017
Pages: 151 - 158
PubMed: 27745535

History

Received: 5 February 2016
Revision received: 4 May 2016
Accepted: 20 May 2016
Published online: 17 October 2016
Published in print: February 01, 2017

Authors

Affiliations

Craig S. Rosen, Ph.D.
Dr. Rosen, Dr. Azevedo, Dr. Tiet, and Ms. Smith are with the National Center for PTSD Dissemination and Training Division, Veterans Affairs (VA) Palo Alto Health Care System, Menlo Park, California (e-mail: [email protected]). Dr. Rosen and Dr. Tiet are also with the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, where Dr. Lindley is affiliated. Dr. Lindley is also with the VA Palo Alto Health Care System, Menlo Park. Dr. Azevedo is also with the Center for Innovation to Implementation, Health Services Research and Development Service, VA Palo Alto Health Care System, Menlo Park, where Dr. Bowe and Dr. Harris are affiliated. Dr. Harris is also with the Department of Surgery, Stanford University School of Medicine, Stanford. Dr. Greene is with the VA Office of Mental Health Services, Menlo Park. Dr. Wood is with Mental Health Services American Lake Division, VA Puget Sound Health Care System, Tacoma, Washington. Dr. Calhoun is with the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC). Dr. Capehart and Dr. Hertzberg are with the Department of Psychiatry, Durham VA Medical Center, Durham, North Carolina. Dr. Calhoun, Dr. Capehart, and Dr. Hertzberg are also with the Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham. Dr. Crawford, formerly with the Clinical Core, Mid-Atlantic Region MIRECC, Durham, is now with the Sheridan VA Medical Center, Sheridan, Wyoming. Mr. Greenbaum is with the VA Sierra-Pacific MIRECC, Menlo Park. Dr. Schnurr is with the National Center for PTSD Executive Division, White River Junction VA Medical Center, White River Junction, Vermont, and the Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
View all articles by this author
Kathryn J. Azevedo, Ph.D.
Dr. Rosen, Dr. Azevedo, Dr. Tiet, and Ms. Smith are with the National Center for PTSD Dissemination and Training Division, Veterans Affairs (VA) Palo Alto Health Care System, Menlo Park, California (e-mail: [email protected]). Dr. Rosen and Dr. Tiet are also with the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, where Dr. Lindley is affiliated. Dr. Lindley is also with the VA Palo Alto Health Care System, Menlo Park. Dr. Azevedo is also with the Center for Innovation to Implementation, Health Services Research and Development Service, VA Palo Alto Health Care System, Menlo Park, where Dr. Bowe and Dr. Harris are affiliated. Dr. Harris is also with the Department of Surgery, Stanford University School of Medicine, Stanford. Dr. Greene is with the VA Office of Mental Health Services, Menlo Park. Dr. Wood is with Mental Health Services American Lake Division, VA Puget Sound Health Care System, Tacoma, Washington. Dr. Calhoun is with the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC). Dr. Capehart and Dr. Hertzberg are with the Department of Psychiatry, Durham VA Medical Center, Durham, North Carolina. Dr. Calhoun, Dr. Capehart, and Dr. Hertzberg are also with the Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham. Dr. Crawford, formerly with the Clinical Core, Mid-Atlantic Region MIRECC, Durham, is now with the Sheridan VA Medical Center, Sheridan, Wyoming. Mr. Greenbaum is with the VA Sierra-Pacific MIRECC, Menlo Park. Dr. Schnurr is with the National Center for PTSD Executive Division, White River Junction VA Medical Center, White River Junction, Vermont, and the Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
View all articles by this author
Quyen Q. Tiet, Ph.D.
Dr. Rosen, Dr. Azevedo, Dr. Tiet, and Ms. Smith are with the National Center for PTSD Dissemination and Training Division, Veterans Affairs (VA) Palo Alto Health Care System, Menlo Park, California (e-mail: [email protected]). Dr. Rosen and Dr. Tiet are also with the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, where Dr. Lindley is affiliated. Dr. Lindley is also with the VA Palo Alto Health Care System, Menlo Park. Dr. Azevedo is also with the Center for Innovation to Implementation, Health Services Research and Development Service, VA Palo Alto Health Care System, Menlo Park, where Dr. Bowe and Dr. Harris are affiliated. Dr. Harris is also with the Department of Surgery, Stanford University School of Medicine, Stanford. Dr. Greene is with the VA Office of Mental Health Services, Menlo Park. Dr. Wood is with Mental Health Services American Lake Division, VA Puget Sound Health Care System, Tacoma, Washington. Dr. Calhoun is with the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC). Dr. Capehart and Dr. Hertzberg are with the Department of Psychiatry, Durham VA Medical Center, Durham, North Carolina. Dr. Calhoun, Dr. Capehart, and Dr. Hertzberg are also with the Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham. Dr. Crawford, formerly with the Clinical Core, Mid-Atlantic Region MIRECC, Durham, is now with the Sheridan VA Medical Center, Sheridan, Wyoming. Mr. Greenbaum is with the VA Sierra-Pacific MIRECC, Menlo Park. Dr. Schnurr is with the National Center for PTSD Executive Division, White River Junction VA Medical Center, White River Junction, Vermont, and the Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
View all articles by this author
Carolyn J. Greene, Ph.D.
Dr. Rosen, Dr. Azevedo, Dr. Tiet, and Ms. Smith are with the National Center for PTSD Dissemination and Training Division, Veterans Affairs (VA) Palo Alto Health Care System, Menlo Park, California (e-mail: [email protected]). Dr. Rosen and Dr. Tiet are also with the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, where Dr. Lindley is affiliated. Dr. Lindley is also with the VA Palo Alto Health Care System, Menlo Park. Dr. Azevedo is also with the Center for Innovation to Implementation, Health Services Research and Development Service, VA Palo Alto Health Care System, Menlo Park, where Dr. Bowe and Dr. Harris are affiliated. Dr. Harris is also with the Department of Surgery, Stanford University School of Medicine, Stanford. Dr. Greene is with the VA Office of Mental Health Services, Menlo Park. Dr. Wood is with Mental Health Services American Lake Division, VA Puget Sound Health Care System, Tacoma, Washington. Dr. Calhoun is with the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC). Dr. Capehart and Dr. Hertzberg are with the Department of Psychiatry, Durham VA Medical Center, Durham, North Carolina. Dr. Calhoun, Dr. Capehart, and Dr. Hertzberg are also with the Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham. Dr. Crawford, formerly with the Clinical Core, Mid-Atlantic Region MIRECC, Durham, is now with the Sheridan VA Medical Center, Sheridan, Wyoming. Mr. Greenbaum is with the VA Sierra-Pacific MIRECC, Menlo Park. Dr. Schnurr is with the National Center for PTSD Executive Division, White River Junction VA Medical Center, White River Junction, Vermont, and the Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
View all articles by this author
Amanda E. Wood, Ph.D.
Dr. Rosen, Dr. Azevedo, Dr. Tiet, and Ms. Smith are with the National Center for PTSD Dissemination and Training Division, Veterans Affairs (VA) Palo Alto Health Care System, Menlo Park, California (e-mail: [email protected]). Dr. Rosen and Dr. Tiet are also with the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, where Dr. Lindley is affiliated. Dr. Lindley is also with the VA Palo Alto Health Care System, Menlo Park. Dr. Azevedo is also with the Center for Innovation to Implementation, Health Services Research and Development Service, VA Palo Alto Health Care System, Menlo Park, where Dr. Bowe and Dr. Harris are affiliated. Dr. Harris is also with the Department of Surgery, Stanford University School of Medicine, Stanford. Dr. Greene is with the VA Office of Mental Health Services, Menlo Park. Dr. Wood is with Mental Health Services American Lake Division, VA Puget Sound Health Care System, Tacoma, Washington. Dr. Calhoun is with the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC). Dr. Capehart and Dr. Hertzberg are with the Department of Psychiatry, Durham VA Medical Center, Durham, North Carolina. Dr. Calhoun, Dr. Capehart, and Dr. Hertzberg are also with the Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham. Dr. Crawford, formerly with the Clinical Core, Mid-Atlantic Region MIRECC, Durham, is now with the Sheridan VA Medical Center, Sheridan, Wyoming. Mr. Greenbaum is with the VA Sierra-Pacific MIRECC, Menlo Park. Dr. Schnurr is with the National Center for PTSD Executive Division, White River Junction VA Medical Center, White River Junction, Vermont, and the Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
View all articles by this author
Patrick Calhoun, Ph.D.
Dr. Rosen, Dr. Azevedo, Dr. Tiet, and Ms. Smith are with the National Center for PTSD Dissemination and Training Division, Veterans Affairs (VA) Palo Alto Health Care System, Menlo Park, California (e-mail: [email protected]). Dr. Rosen and Dr. Tiet are also with the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, where Dr. Lindley is affiliated. Dr. Lindley is also with the VA Palo Alto Health Care System, Menlo Park. Dr. Azevedo is also with the Center for Innovation to Implementation, Health Services Research and Development Service, VA Palo Alto Health Care System, Menlo Park, where Dr. Bowe and Dr. Harris are affiliated. Dr. Harris is also with the Department of Surgery, Stanford University School of Medicine, Stanford. Dr. Greene is with the VA Office of Mental Health Services, Menlo Park. Dr. Wood is with Mental Health Services American Lake Division, VA Puget Sound Health Care System, Tacoma, Washington. Dr. Calhoun is with the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC). Dr. Capehart and Dr. Hertzberg are with the Department of Psychiatry, Durham VA Medical Center, Durham, North Carolina. Dr. Calhoun, Dr. Capehart, and Dr. Hertzberg are also with the Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham. Dr. Crawford, formerly with the Clinical Core, Mid-Atlantic Region MIRECC, Durham, is now with the Sheridan VA Medical Center, Sheridan, Wyoming. Mr. Greenbaum is with the VA Sierra-Pacific MIRECC, Menlo Park. Dr. Schnurr is with the National Center for PTSD Executive Division, White River Junction VA Medical Center, White River Junction, Vermont, and the Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
View all articles by this author
Thomas Bowe, Ph.D.
Dr. Rosen, Dr. Azevedo, Dr. Tiet, and Ms. Smith are with the National Center for PTSD Dissemination and Training Division, Veterans Affairs (VA) Palo Alto Health Care System, Menlo Park, California (e-mail: [email protected]). Dr. Rosen and Dr. Tiet are also with the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, where Dr. Lindley is affiliated. Dr. Lindley is also with the VA Palo Alto Health Care System, Menlo Park. Dr. Azevedo is also with the Center for Innovation to Implementation, Health Services Research and Development Service, VA Palo Alto Health Care System, Menlo Park, where Dr. Bowe and Dr. Harris are affiliated. Dr. Harris is also with the Department of Surgery, Stanford University School of Medicine, Stanford. Dr. Greene is with the VA Office of Mental Health Services, Menlo Park. Dr. Wood is with Mental Health Services American Lake Division, VA Puget Sound Health Care System, Tacoma, Washington. Dr. Calhoun is with the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC). Dr. Capehart and Dr. Hertzberg are with the Department of Psychiatry, Durham VA Medical Center, Durham, North Carolina. Dr. Calhoun, Dr. Capehart, and Dr. Hertzberg are also with the Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham. Dr. Crawford, formerly with the Clinical Core, Mid-Atlantic Region MIRECC, Durham, is now with the Sheridan VA Medical Center, Sheridan, Wyoming. Mr. Greenbaum is with the VA Sierra-Pacific MIRECC, Menlo Park. Dr. Schnurr is with the National Center for PTSD Executive Division, White River Junction VA Medical Center, White River Junction, Vermont, and the Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
View all articles by this author
Bruce P. Capehart, M.D.
Dr. Rosen, Dr. Azevedo, Dr. Tiet, and Ms. Smith are with the National Center for PTSD Dissemination and Training Division, Veterans Affairs (VA) Palo Alto Health Care System, Menlo Park, California (e-mail: [email protected]). Dr. Rosen and Dr. Tiet are also with the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, where Dr. Lindley is affiliated. Dr. Lindley is also with the VA Palo Alto Health Care System, Menlo Park. Dr. Azevedo is also with the Center for Innovation to Implementation, Health Services Research and Development Service, VA Palo Alto Health Care System, Menlo Park, where Dr. Bowe and Dr. Harris are affiliated. Dr. Harris is also with the Department of Surgery, Stanford University School of Medicine, Stanford. Dr. Greene is with the VA Office of Mental Health Services, Menlo Park. Dr. Wood is with Mental Health Services American Lake Division, VA Puget Sound Health Care System, Tacoma, Washington. Dr. Calhoun is with the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC). Dr. Capehart and Dr. Hertzberg are with the Department of Psychiatry, Durham VA Medical Center, Durham, North Carolina. Dr. Calhoun, Dr. Capehart, and Dr. Hertzberg are also with the Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham. Dr. Crawford, formerly with the Clinical Core, Mid-Atlantic Region MIRECC, Durham, is now with the Sheridan VA Medical Center, Sheridan, Wyoming. Mr. Greenbaum is with the VA Sierra-Pacific MIRECC, Menlo Park. Dr. Schnurr is with the National Center for PTSD Executive Division, White River Junction VA Medical Center, White River Junction, Vermont, and the Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
View all articles by this author
Eric F. Crawford, Ph.D.
Dr. Rosen, Dr. Azevedo, Dr. Tiet, and Ms. Smith are with the National Center for PTSD Dissemination and Training Division, Veterans Affairs (VA) Palo Alto Health Care System, Menlo Park, California (e-mail: [email protected]). Dr. Rosen and Dr. Tiet are also with the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, where Dr. Lindley is affiliated. Dr. Lindley is also with the VA Palo Alto Health Care System, Menlo Park. Dr. Azevedo is also with the Center for Innovation to Implementation, Health Services Research and Development Service, VA Palo Alto Health Care System, Menlo Park, where Dr. Bowe and Dr. Harris are affiliated. Dr. Harris is also with the Department of Surgery, Stanford University School of Medicine, Stanford. Dr. Greene is with the VA Office of Mental Health Services, Menlo Park. Dr. Wood is with Mental Health Services American Lake Division, VA Puget Sound Health Care System, Tacoma, Washington. Dr. Calhoun is with the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC). Dr. Capehart and Dr. Hertzberg are with the Department of Psychiatry, Durham VA Medical Center, Durham, North Carolina. Dr. Calhoun, Dr. Capehart, and Dr. Hertzberg are also with the Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham. Dr. Crawford, formerly with the Clinical Core, Mid-Atlantic Region MIRECC, Durham, is now with the Sheridan VA Medical Center, Sheridan, Wyoming. Mr. Greenbaum is with the VA Sierra-Pacific MIRECC, Menlo Park. Dr. Schnurr is with the National Center for PTSD Executive Division, White River Junction VA Medical Center, White River Junction, Vermont, and the Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
View all articles by this author
Mark A. Greenbaum, M.S., M.A.
Dr. Rosen, Dr. Azevedo, Dr. Tiet, and Ms. Smith are with the National Center for PTSD Dissemination and Training Division, Veterans Affairs (VA) Palo Alto Health Care System, Menlo Park, California (e-mail: [email protected]). Dr. Rosen and Dr. Tiet are also with the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, where Dr. Lindley is affiliated. Dr. Lindley is also with the VA Palo Alto Health Care System, Menlo Park. Dr. Azevedo is also with the Center for Innovation to Implementation, Health Services Research and Development Service, VA Palo Alto Health Care System, Menlo Park, where Dr. Bowe and Dr. Harris are affiliated. Dr. Harris is also with the Department of Surgery, Stanford University School of Medicine, Stanford. Dr. Greene is with the VA Office of Mental Health Services, Menlo Park. Dr. Wood is with Mental Health Services American Lake Division, VA Puget Sound Health Care System, Tacoma, Washington. Dr. Calhoun is with the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC). Dr. Capehart and Dr. Hertzberg are with the Department of Psychiatry, Durham VA Medical Center, Durham, North Carolina. Dr. Calhoun, Dr. Capehart, and Dr. Hertzberg are also with the Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham. Dr. Crawford, formerly with the Clinical Core, Mid-Atlantic Region MIRECC, Durham, is now with the Sheridan VA Medical Center, Sheridan, Wyoming. Mr. Greenbaum is with the VA Sierra-Pacific MIRECC, Menlo Park. Dr. Schnurr is with the National Center for PTSD Executive Division, White River Junction VA Medical Center, White River Junction, Vermont, and the Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
View all articles by this author
Alex H. S. Harris, Ph.D.
Dr. Rosen, Dr. Azevedo, Dr. Tiet, and Ms. Smith are with the National Center for PTSD Dissemination and Training Division, Veterans Affairs (VA) Palo Alto Health Care System, Menlo Park, California (e-mail: [email protected]). Dr. Rosen and Dr. Tiet are also with the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, where Dr. Lindley is affiliated. Dr. Lindley is also with the VA Palo Alto Health Care System, Menlo Park. Dr. Azevedo is also with the Center for Innovation to Implementation, Health Services Research and Development Service, VA Palo Alto Health Care System, Menlo Park, where Dr. Bowe and Dr. Harris are affiliated. Dr. Harris is also with the Department of Surgery, Stanford University School of Medicine, Stanford. Dr. Greene is with the VA Office of Mental Health Services, Menlo Park. Dr. Wood is with Mental Health Services American Lake Division, VA Puget Sound Health Care System, Tacoma, Washington. Dr. Calhoun is with the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC). Dr. Capehart and Dr. Hertzberg are with the Department of Psychiatry, Durham VA Medical Center, Durham, North Carolina. Dr. Calhoun, Dr. Capehart, and Dr. Hertzberg are also with the Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham. Dr. Crawford, formerly with the Clinical Core, Mid-Atlantic Region MIRECC, Durham, is now with the Sheridan VA Medical Center, Sheridan, Wyoming. Mr. Greenbaum is with the VA Sierra-Pacific MIRECC, Menlo Park. Dr. Schnurr is with the National Center for PTSD Executive Division, White River Junction VA Medical Center, White River Junction, Vermont, and the Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
View all articles by this author
Michael Hertzberg, M.D.
Dr. Rosen, Dr. Azevedo, Dr. Tiet, and Ms. Smith are with the National Center for PTSD Dissemination and Training Division, Veterans Affairs (VA) Palo Alto Health Care System, Menlo Park, California (e-mail: [email protected]). Dr. Rosen and Dr. Tiet are also with the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, where Dr. Lindley is affiliated. Dr. Lindley is also with the VA Palo Alto Health Care System, Menlo Park. Dr. Azevedo is also with the Center for Innovation to Implementation, Health Services Research and Development Service, VA Palo Alto Health Care System, Menlo Park, where Dr. Bowe and Dr. Harris are affiliated. Dr. Harris is also with the Department of Surgery, Stanford University School of Medicine, Stanford. Dr. Greene is with the VA Office of Mental Health Services, Menlo Park. Dr. Wood is with Mental Health Services American Lake Division, VA Puget Sound Health Care System, Tacoma, Washington. Dr. Calhoun is with the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC). Dr. Capehart and Dr. Hertzberg are with the Department of Psychiatry, Durham VA Medical Center, Durham, North Carolina. Dr. Calhoun, Dr. Capehart, and Dr. Hertzberg are also with the Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham. Dr. Crawford, formerly with the Clinical Core, Mid-Atlantic Region MIRECC, Durham, is now with the Sheridan VA Medical Center, Sheridan, Wyoming. Mr. Greenbaum is with the VA Sierra-Pacific MIRECC, Menlo Park. Dr. Schnurr is with the National Center for PTSD Executive Division, White River Junction VA Medical Center, White River Junction, Vermont, and the Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
View all articles by this author
Steven E. Lindley, M.D., Ph.D.
Dr. Rosen, Dr. Azevedo, Dr. Tiet, and Ms. Smith are with the National Center for PTSD Dissemination and Training Division, Veterans Affairs (VA) Palo Alto Health Care System, Menlo Park, California (e-mail: [email protected]). Dr. Rosen and Dr. Tiet are also with the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, where Dr. Lindley is affiliated. Dr. Lindley is also with the VA Palo Alto Health Care System, Menlo Park. Dr. Azevedo is also with the Center for Innovation to Implementation, Health Services Research and Development Service, VA Palo Alto Health Care System, Menlo Park, where Dr. Bowe and Dr. Harris are affiliated. Dr. Harris is also with the Department of Surgery, Stanford University School of Medicine, Stanford. Dr. Greene is with the VA Office of Mental Health Services, Menlo Park. Dr. Wood is with Mental Health Services American Lake Division, VA Puget Sound Health Care System, Tacoma, Washington. Dr. Calhoun is with the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC). Dr. Capehart and Dr. Hertzberg are with the Department of Psychiatry, Durham VA Medical Center, Durham, North Carolina. Dr. Calhoun, Dr. Capehart, and Dr. Hertzberg are also with the Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham. Dr. Crawford, formerly with the Clinical Core, Mid-Atlantic Region MIRECC, Durham, is now with the Sheridan VA Medical Center, Sheridan, Wyoming. Mr. Greenbaum is with the VA Sierra-Pacific MIRECC, Menlo Park. Dr. Schnurr is with the National Center for PTSD Executive Division, White River Junction VA Medical Center, White River Junction, Vermont, and the Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
View all articles by this author
Brandy N. Smith, B.A.
Dr. Rosen, Dr. Azevedo, Dr. Tiet, and Ms. Smith are with the National Center for PTSD Dissemination and Training Division, Veterans Affairs (VA) Palo Alto Health Care System, Menlo Park, California (e-mail: [email protected]). Dr. Rosen and Dr. Tiet are also with the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, where Dr. Lindley is affiliated. Dr. Lindley is also with the VA Palo Alto Health Care System, Menlo Park. Dr. Azevedo is also with the Center for Innovation to Implementation, Health Services Research and Development Service, VA Palo Alto Health Care System, Menlo Park, where Dr. Bowe and Dr. Harris are affiliated. Dr. Harris is also with the Department of Surgery, Stanford University School of Medicine, Stanford. Dr. Greene is with the VA Office of Mental Health Services, Menlo Park. Dr. Wood is with Mental Health Services American Lake Division, VA Puget Sound Health Care System, Tacoma, Washington. Dr. Calhoun is with the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC). Dr. Capehart and Dr. Hertzberg are with the Department of Psychiatry, Durham VA Medical Center, Durham, North Carolina. Dr. Calhoun, Dr. Capehart, and Dr. Hertzberg are also with the Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham. Dr. Crawford, formerly with the Clinical Core, Mid-Atlantic Region MIRECC, Durham, is now with the Sheridan VA Medical Center, Sheridan, Wyoming. Mr. Greenbaum is with the VA Sierra-Pacific MIRECC, Menlo Park. Dr. Schnurr is with the National Center for PTSD Executive Division, White River Junction VA Medical Center, White River Junction, Vermont, and the Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
View all articles by this author
Paula P. Schnurr, Ph.D.
Dr. Rosen, Dr. Azevedo, Dr. Tiet, and Ms. Smith are with the National Center for PTSD Dissemination and Training Division, Veterans Affairs (VA) Palo Alto Health Care System, Menlo Park, California (e-mail: [email protected]). Dr. Rosen and Dr. Tiet are also with the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, where Dr. Lindley is affiliated. Dr. Lindley is also with the VA Palo Alto Health Care System, Menlo Park. Dr. Azevedo is also with the Center for Innovation to Implementation, Health Services Research and Development Service, VA Palo Alto Health Care System, Menlo Park, where Dr. Bowe and Dr. Harris are affiliated. Dr. Harris is also with the Department of Surgery, Stanford University School of Medicine, Stanford. Dr. Greene is with the VA Office of Mental Health Services, Menlo Park. Dr. Wood is with Mental Health Services American Lake Division, VA Puget Sound Health Care System, Tacoma, Washington. Dr. Calhoun is with the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC). Dr. Capehart and Dr. Hertzberg are with the Department of Psychiatry, Durham VA Medical Center, Durham, North Carolina. Dr. Calhoun, Dr. Capehart, and Dr. Hertzberg are also with the Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham. Dr. Crawford, formerly with the Clinical Core, Mid-Atlantic Region MIRECC, Durham, is now with the Sheridan VA Medical Center, Sheridan, Wyoming. Mr. Greenbaum is with the VA Sierra-Pacific MIRECC, Menlo Park. Dr. Schnurr is with the National Center for PTSD Executive Division, White River Junction VA Medical Center, White River Junction, Vermont, and the Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
View all articles by this author

Competing Interests

The authors report no financial relationships with commercial interests.

Funding Information

Congressionally Directed Medical Research Programs10.13039/100000090: W81XWH-08-2-0096
This study is registered on Clinicaltrials.gov as NCT02655991. This research was supported by the Congressionally Directed Medical Research Program, grant W81XWH-08-2-0096 awarded to Dr. Rosen. The authors thank the veterans who participated in this research; the VA staff members who supported this study; study coordinator Emerald Adler; and Kathy Blau, Julia Hernandez, Nate Hawkins, Niall Kavanagh, Caitlin McLean, and Olga Rosito, who provided compassionate telephone support to the veterans in this trial. The opinions expressed are those of the authors and do not represent the position of the U.S. Department of Veterans Affairs.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Item saved, go to cart
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share